HMGBiotech Srl has taken part to a study, published in June, in which are discovered CXCL12 as the first fuzzy chemokines heterocomplex reported so far and the unexpected role of the acidic intrinsically disordered region (IDR), in HMGB1●CXCL12 heterocomplex formation.
Anti-inflammatory pharmacological research: unexplored opportunities unveiled Read More »
A new research, in which HMGBiotech Srl participated, has unmasked an unexpected player in the world of chemokine interactions: the acidic intrinsically disordered region (IDR).
On 28th June, Dr Andrea Lamarca, researcher in HMGBiotech lab, will give a speech at IMIG2023, the International Mesothelioma Interest Group conference.
28th June 2023: speech at IMIG Read More »
HMGBiotech participated in a recent study in which, through an integrative structural approach, molecular details of HMGB1●CXCL12 heterocomplex formation were unveiled.
HMGB1●CXCL12 : the first fuzzy chemokines heterocomplex reported so far Read More »
The interaction between SDF-1 chemokine protein (CXCL12) and HMGB1 generates an heterocomplex which plays an unique role in homeostatic regulation.
Combination kit SDF-1 chemokine protein (CXCL12) with HMGB1 isoforms Read More »
Contact us if you want a dedicated consulting or if you have any questions about our products
Pre-sales consulting and questions Read More »
Disulfide-HMGB1 is a recombinant protein that can induce cytokine and chemokine production in monocytes and other inflammatory cells.
Discover our oxidized HMGB1 protein (disulfide-HMGB1) Read More »
Deeplearning language model applied to design proteins sequence
Deeplearning language model & design proteins sequence Read More »
HMGBiotech Srl will join IMIG2023 through a workshop speech by Dr. Andrea Lamarca.
HMGBiotech will join IMIG2023 Read More »
We and selected third parties use cookies or similar technologies for technical purposes and, with your consent, for experience, measurement and marketing (personalised ads) as specified in the cookie policy. You can freely give, deny, or withdraw your consent at any time by accessing the preferences panel. Denying consent may make related features unavailable. Use the “Accept” button to consent. Use the “Reject” button or close this notice to continue without accepting.